| Literature DB >> 31501071 |
Antonia García Martín1, Mariela Varsavsky2, María Cortés Berdonces3, Verónica Ávila Rubio4, María Rosa Alhambra Expósito5, Cristina Novo Rodríguez6, Pedro Rozas Moreno7, Manuel Romero Muñoz8, Esteban Jódar Gimeno9, Pilar Rodríguez Ortega10, Manuel Muñoz Torres11.
Abstract
Serum phosphorus levels range from 2.5 and 4.5mg/dL (0.81-1.45 mmol/L) in adults, with higher levels in childhood, adolescence, and pregnancy. Intracellular phosphate is involved in intermediary metabolism and other essential cell functions, while extracellular phosphate is essential for bone matrix mineralization. Plasma phosphorus levels are maintained within a narrow range by regulation of intestinal absorption, redistribution, and renal tubular absorption of the mineral. Hypophosphatemia and hyperphosphatemia are common clinical situations, although changes are most often mild and oligosymptomatic. However, acute and severe conditions that require specific treatment may occur. In this document, members of the Mineral and Bone Metabolism Working Group of the Spanish Society of Endocrinology and Nutrition review phosphate disorders and provide algorithms for adequate clinical management of hypophosphatemia and hyperphosphatemia.Entities:
Keywords: Fósforo sérico; Hiperfosfatemia; Hipofosfatemia; Hyperphosphatemia; Hypophosphatemia; Serum phosphorus
Mesh:
Substances:
Year: 2019 PMID: 31501071 DOI: 10.1016/j.endinu.2019.06.004
Source DB: PubMed Journal: Endocrinol Diabetes Nutr (Engl Ed) ISSN: 2530-0180 Impact factor: 1.417